Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niccola Funel

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Practical Laboratory Medicine|February 3, 2025
Complete blood count in neonatal Intensive care Unit (NICU): Performance comparison between POCT Sight OLO® and Sysmex XN-9100™ hematology analyzersFrancesca Nencini, Alessandro Bonari, Sara Ciullini Mannurita, et al.
World Journal of Gastroenterology|June 20, 2020
Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicineGregorio Di Franco, Alice Usai, Niccola Funel, et al.
Cancers|August 27, 2021
Zebrafish Patient-Derived Xenografts Identify Chemo-Response in Pancreatic Ductal Adenocarcinoma PatientsAlice Usai, Gregorio Di Franco, Margherita Piccardi, et al.
European Journal of Pharmacology|February 18, 2014
Anti-diabetic properties of a non-conventional radical scavenger, as compared to pioglitazone and exendin-4, in streptozotocin-nicotinamide diabetic miceMichela Novelli, Donatella Canistro, Manuela Martano, et al.
Journal of the National Cancer Institute|December 5, 2013
Role of CYB5A in pancreatic cancer prognosis and autophagy modulationElisa Giovannetti, Qiuyan Wang, Amir Avan, et al.
Cancer Research|May 13, 2010
MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activityElisa Giovannetti, Niccola Funel, Godefridus J Peters, et al.
Cancers|May 11, 2019
Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate CellsOmidreza Firuzi, Pei Pei Che, Btissame El Hassouni, et al.
Cancers|August 25, 2019
Unravelling the Diagnostic Dilemma: A MicroRNA Panel of Circulating MiR-16 and MiR-877 as A Diagnostic Classifier for Distal Bile Duct TumorsLaura L Meijer, Jisce R Puik, Tessa Y S Le Large, et al.
Abdominal Imaging|March 28, 2007
Evaluation of vascular infiltration in resected patients for pancreatic cancer: comparison among multidetector CT, intraoperative findings and histopathologySalvatore Mazzeo, Carla Cappelli, Davide Caramella, et al.
Pharmacogenomics|May 7, 2014
A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patientsMina Maftouh, Amir Avan, Niccola Funel, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Practical Laboratory Medicine|February 3, 2025
Complete blood count in neonatal Intensive care Unit (NICU): Performance comparison between POCT Sight OLO® and Sysmex XN-9100™ hematology analyzersFrancesca Nencini, Alessandro Bonari, Sara Ciullini Mannurita, et al.
World Journal of Gastroenterology|June 20, 2020
Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicineGregorio Di Franco, Alice Usai, Niccola Funel, et al.
Cancers|August 27, 2021
Zebrafish Patient-Derived Xenografts Identify Chemo-Response in Pancreatic Ductal Adenocarcinoma PatientsAlice Usai, Gregorio Di Franco, Margherita Piccardi, et al.
European Journal of Pharmacology|February 18, 2014
Anti-diabetic properties of a non-conventional radical scavenger, as compared to pioglitazone and exendin-4, in streptozotocin-nicotinamide diabetic miceMichela Novelli, Donatella Canistro, Manuela Martano, et al.
Journal of the National Cancer Institute|December 5, 2013
Role of CYB5A in pancreatic cancer prognosis and autophagy modulationElisa Giovannetti, Qiuyan Wang, Amir Avan, et al.
Cancer Research|May 13, 2010
MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activityElisa Giovannetti, Niccola Funel, Godefridus J Peters, et al.
Cancers|May 11, 2019
Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate CellsOmidreza Firuzi, Pei Pei Che, Btissame El Hassouni, et al.
Cancers|August 25, 2019
Unravelling the Diagnostic Dilemma: A MicroRNA Panel of Circulating MiR-16 and MiR-877 as A Diagnostic Classifier for Distal Bile Duct TumorsLaura L Meijer, Jisce R Puik, Tessa Y S Le Large, et al.
Abdominal Imaging|March 28, 2007
Evaluation of vascular infiltration in resected patients for pancreatic cancer: comparison among multidetector CT, intraoperative findings and histopathologySalvatore Mazzeo, Carla Cappelli, Davide Caramella, et al.
Pharmacogenomics|May 7, 2014
A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patientsMina Maftouh, Amir Avan, Niccola Funel, et al.
Pageof 10